Retinal Structural and Vascular Changes in Patients with Coronary Artery Disease: A Systematic Review and Meta-Analysis

• Published in: Life (Basel, Switzerland) Vol. 14; no. 4; p. 448
• Main Authors: Rusu, Alexandra Cristina, Horvath, Karin Ursula, Tinica, Grigore, Chistol, Raluca Ozana, Bulgaru-Iliescu, Andra-Irina, Todosia, Ecaterina Tomaziu, Brînzaniuc, Klara
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2024
• Subjects: Angiography; Biomarkers; Blood vessels; Cardiovascular disease; Care and treatment; Carotid arteries; Carotid artery; Complications and side effects; Coronary artery disease; Coronary heart disease; Coronary vessels; Density; Development and progression; Diabetes mellitus; Heart diseases; Heart failure; Heterogeneity; Hypertension; Mean; Medical imaging; Meta-analysis; microvascularization; Microvasculature; Mortality; Optical Coherence Tomography; optical coherence tomography angiography; Patients; Retina; retinal; Retinal diseases; Risk factors; Romania; Standard deviation; Statistical analysis; Thickness; Tomography; Type 2 diabetes; Vascularization; Vein & artery diseases; Romania; coronary artery disease; meta-analysis; microvascularization; retinal; optical coherence tomography angiography
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life14040448

Retinal microvascular anomalies have been identified in patients with cardiovascular conditions such as arterial hypertension, diabetes mellitus, and carotid artery disease. We conducted a systematic review and meta-analysis (PROSPERO registration number CRD42024506589) to explore the potential of retinal vasculature as a biomarker for diagnosis and monitoring of patients with coronary artery disease (CAD) through optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). We systematically examined original articles in the Pubmed, Embase, and Web of Science databases from their inception up to November 2023, comparing retinal microvascular features between patients with CAD and control groups. Studies were included if they reported sample mean with standard deviation or median with range and/or interquartile range (which were computed into mean and standard deviation). Review Manager 5.4 (The Cochrane Collaboration, 2020) software was used to calculate the pooled effect size with weighted mean difference and 95% confidence intervals (CI) by random-effects inverse variance method. Eleven studies meeting the inclusion criteria were incorporated into the meta-analysis. The findings indicated a significant decrease in the retinal nerve fiber layer (WMD -3.11 [-6.06, -0.16]), subfoveal choroid (WMD -58.79 [-64.65, -52.93]), and overall retinal thickness (WMD -4.61 [-7.05, -2.17]) among patients with CAD compared to controls ( < 0.05). Furthermore, vascular macular density was notably lower in CAD patients, particularly in the superficial capillary plexus (foveal vessel density WMD -2.19 [-3.02, -1.135], < 0.0001). Additionally, the foveal avascular zone area was statistically larger in CAD patients compared to the control group (WMD 52.73 [8.79, 96.67], = 0.02). Heterogeneity was significant (I > 50%) for most features except for subfoveal choroid thickness, retina thickness, and superficial foveal vessel density. The current meta-analysis suggests that retinal vascularization could function as a noninvasive biomarker, providing additional insights beyond standard routine examinations for assessing dysfunction in coronary arteries.